Search
for
Sort by
Research 511–540 of 1000+
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Keratosis pilaris atrophicans faciei: An observational, descriptive, retrospective clinical study
- Workup and Management of Polycystic Ovary Syndrome
- Hair: A Review of Prominent Scalp Hair Changes throughout a Females’ Life
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Ethosomes: An Exciting and Promising Alcoholic Carrier System for Treating Androgenic Alopecia
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- THY1-mediated mechanisms converge to drive YAP activation in skin homeostasis and repair
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Apoptosis in Hair and Skin: A Review
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Immunohistochemical and autoradiographic findings suggest that minoxidil is not localized in specific cells of vibrissa, pelage, or scalp follicles
- MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Dissolving microneedles for alopecia treatment
- Review on Tridax Procumbens
- Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies
- Computational Drug Discovery in Chemotherapy-induced Alopecia via Text Mining and Biomedical Databases
- Chemotherapy‐induced alopecia: an exploratory questionnaire‐based study from Israel comparing knowledge, attitudes, and management practices among dermatologists and oncologists